Sait Okkan

883 total citations
39 papers, 654 citations indexed

About

Sait Okkan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Sait Okkan has authored 39 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Obstetrics and Gynecology. Recurrent topics in Sait Okkan's work include Endometrial and Cervical Cancer Treatments (11 papers), Advanced Radiotherapy Techniques (7 papers) and Cancer Risks and Factors (5 papers). Sait Okkan is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Advanced Radiotherapy Techniques (7 papers) and Cancer Risks and Factors (5 papers). Sait Okkan collaborates with scholars based in Türkiye, India and Austria. Sait Okkan's co-authors include Gül Alço, Şefik İğdem, Ömer Uzel, Sedat Türkan, Jean-François Delaloye, B. Frankendal, Bengt Sorbe, Johanna Mäenpää, Britta Nordström and Maktav Dinçer and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

Sait Okkan

38 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sait Okkan Türkiye 15 212 189 183 173 152 39 654
Chawalit Lertbutsayanukul Thailand 12 130 0.6× 136 0.7× 179 1.0× 118 0.7× 95 0.6× 50 500
Mauricio Cambeiro Spain 16 126 0.6× 289 1.5× 298 1.6× 333 1.9× 74 0.5× 64 715
T. Messaï France 10 201 0.9× 80 0.4× 148 0.8× 165 1.0× 40 0.3× 17 471
C. Haie France 11 309 1.5× 166 0.9× 221 1.2× 175 1.0× 44 0.3× 27 677
L. Gonzague-Casabianca France 11 197 0.9× 56 0.3× 116 0.6× 89 0.5× 75 0.5× 23 420
Karine Peignaux France 13 91 0.4× 235 1.2× 292 1.6× 264 1.5× 69 0.5× 46 617
Tomoko Kazumoto Japan 14 218 1.0× 176 0.9× 344 1.9× 215 1.2× 31 0.2× 32 668
Sea-Won Lee South Korea 13 110 0.5× 90 0.5× 129 0.7× 150 0.9× 77 0.5× 37 423
Noriko Ii Japan 13 135 0.6× 146 0.8× 185 1.0× 200 1.2× 30 0.2× 40 519
Kim Cao France 12 121 0.6× 169 0.9× 158 0.9× 153 0.9× 62 0.4× 45 456

Countries citing papers authored by Sait Okkan

Since Specialization
Citations

This map shows the geographic impact of Sait Okkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sait Okkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sait Okkan more than expected).

Fields of papers citing papers by Sait Okkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sait Okkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sait Okkan. The network helps show where Sait Okkan may publish in the future.

Co-authorship network of co-authors of Sait Okkan

This figure shows the co-authorship network connecting the top 25 collaborators of Sait Okkan. A scholar is included among the top collaborators of Sait Okkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sait Okkan. Sait Okkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alço, Gül, Şefik İğdem, Sait Okkan, et al.. (2016). Replacement of the tumor bed following oncoplastic breast-conserving surgery with immediate latissimus dorsi mini-flap. Molecular and Clinical Oncology. 5(4). 365–371. 21 indexed citations
2.
Ordu, Çetın, Kandace P. McGuire, Gül Alço, et al.. (2016). The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer. Cureus. 8(6). e633–e633. 6 indexed citations
3.
Pilancı, Kezban Nur, Gül Alço, Çetın Ordu, et al.. (2015). Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?. Medicine. 94(18). e671–e671. 18 indexed citations
4.
Alço, Gül, Kezban Nur Pilancı, Sıtkı Tuzlalı, et al.. (2015). Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients. Oncology Letters. 9(3). 1046–1054. 23 indexed citations
5.
Alço, Gül, Şefik İğdem, Maktav Dinçer, et al.. (2014). Vitamin D Levels in Patients with Breast Cancer: Importance of Dressing Style. Asian Pacific Journal of Cancer Prevention. 15(3). 1357–1362. 18 indexed citations
6.
Ober, Angelika, et al.. (2012). Radiotherapy for benign diseases: a retrospective analysis.. PubMed. 9(1). 57–61. 1 indexed citations
7.
İğdem, Şefik, et al.. (2010). Dosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer. Japanese Journal of Radiology. 28(4). 283–289. 33 indexed citations
8.
Alço, Gül, et al.. (2010). Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy. British Journal of Radiology. 83(996). 1072–1076. 46 indexed citations
10.
Okkan, Sait, et al.. (2010). Radiotherapy with or without temozolomide in elderly glioblastoma patients: Treatment results and prognostic factors.. Journal of Clinical Oncology. 28(15_suppl). 2048–2048. 3 indexed citations
11.
İğdem, Şefik, Daphna Y. Spiegel, Jason A. Efstathiou, et al.. (2010). Prostatic Duct Adenocarcinoma: Clinical Characteristics, Treatment Options, and Outcomes – a Rare Cancer Network Study. Onkologie. 33(4). 169–173. 16 indexed citations
12.
Sorbe, Bengt, Britta Nordström, Johanna Mäenpää, et al.. (2009). Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer. International Journal of Gynecological Cancer. 19(5). 873–878. 111 indexed citations
13.
İğdem, Şefik, et al.. (2009). Insufficiency Fractures After Pelvic Radiotherapy in Patients With Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(3). 818–823. 55 indexed citations
14.
Dobrowsky, W., et al.. (2005). AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage iii cancer cervix: Initial results of an IAEA multicentre randomized trial. Journal of Cancer Research and Therapeutics. 1(2). 75–75. 11 indexed citations
15.
Çepni, İsmail, et al.. (2004). Tandem application with transvaginal ultrasound guidance. International Journal of Radiation Oncology*Biology*Physics. 59(1). 190–196. 12 indexed citations
16.
Atalar, Banu, et al.. (2004). Postoperative radiotherapy in the treatment of uterine sarcomas: Long-term results and analysis of prognostic factors. Journal of Clinical Oncology. 22(14_suppl). 9045–9045. 1 indexed citations
17.
Okkan, Sait, et al.. (2003). Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience. Radiotherapy and Oncology. 67(1). 97–105. 13 indexed citations
18.
Okkan, Sait, et al.. (2001). Endometrial Carcinoma and an Unusual Presentation of Bone Metastasis: A Case Report. Gynecologic Oncology. 82(1). 216–218. 33 indexed citations
19.
Beşe, Nuran, Ömer Uzel, Sedat Türkan, & Sait Okkan. (1998). Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas. Radiotherapy and Oncology. 47(2). 197–200. 7 indexed citations
20.
Dinçbaş, Fazilet Öner, et al.. (1995). Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma. Radiotherapy and Oncology. 37(1). 10–16. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026